Oruka Therapeutics, Inc. (ORKA)
95.81
+5.48
(+6.07%)
USD |
NASDAQ |
Oct 27, 16:00
95.70
-0.11
(-0.11%)
Pre-Market: 08:43
Oruka Therapeutics Net Income (Quarterly) : -41.21M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -41.21M |
| March 31, 2026 | -31.82M |
| December 31, 2025 | -29.58M |
| September 30, 2025 | -30.28M |
| June 30, 2025 | -24.57M |
| March 31, 2025 | -21.00M |
| December 31, 2024 | -25.78M |
| September 30, 2024 | -28.62M |
| June 30, 2024 | -22.24M |
| March 31, 2024 | -7.077M |
| December 31, 2023 | -1.089M |
| September 30, 2023 | -1.424M |
| June 30, 2023 | -1.48M |
| March 31, 2023 | -1.346M |
| December 31, 2022 | -1.174M |
| September 30, 2022 | -2.333M |
| June 30, 2022 | -3.147M |
| March 31, 2022 | -3.272M |
| December 31, 2021 | -5.676M |
| September 30, 2021 | -4.712M |
| June 30, 2021 | -4.834M |
| March 31, 2021 | -4.10M |
| December 31, 2020 | -5.125M |
| September 30, 2020 | -1.991M |
| June 30, 2020 | -1.302M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.32M |
| December 31, 2019 | -1.226M |
| September 30, 2019 | -1.156M |
| June 30, 2019 | -1.436M |
| March 31, 2019 | -1.664M |
| December 31, 2018 | -1.489M |
| September 30, 2018 | -1.593M |
| June 30, 2018 | -2.116M |
| March 31, 2018 | -2.735M |
| December 31, 2017 | -4.197M |
| September 30, 2017 | -4.433M |
| June 30, 2017 | -5.522M |
| March 31, 2017 | -4.338M |
| December 31, 2016 | -4.244M |
| September 30, 2016 | -4.659M |
| June 30, 2016 | -3.894M |
| March 31, 2016 | -3.647M |
| December 31, 2015 | -3.168M |
| September 30, 2015 | -2.814M |
| June 30, 2015 | -2.719M |
| March 31, 2015 | -2.744M |
| December 31, 2014 | -2.611M |
| September 30, 2014 | -2.284M |
| June 30, 2014 | -2.405M |
| March 31, 2014 | -2.389M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -17.80M |
| Exicure, Inc. | -1.121M |
| Century Therapeutics, Inc. | -34.55M |
| Absci Corp. | -33.21M |
| Celularity, Inc. | 0.546M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 41.21M |
| EPS Diluted (Quarterly) | -0.6554 |
| Enterprise Value | 4.983B |
| Earnings Yield | -2.57% |
| Normalized Earnings Yield | -2.570 |